Connection
Stanley Szefler to Methylprednisolone
This is a "connection" page, showing publications Stanley Szefler has written about Methylprednisolone.
|
|
Connection Strength |
|
|
|
|
|
0.753 |
|
|
|
-
Spahn JD, Leung DY, Surs W, Harbeck RJ, Nimmagadda S, Szefler SJ. Reduced glucocorticoid binding affinity in asthma is related to ongoing allergic inflammation. Am J Respir Crit Care Med. 1995 Jun; 151(6):1709-14.
Score: 0.122
-
Kamada AK, Spahn JD, Surs W, Brown E, Leung DY, Szefler SJ. Coexistence of glucocorticoid receptor and pharmacokinetic abnormalities: factors that contribute to a poor response to treatment with glucocorticoids in children with asthma. J Pediatr. 1994 Jun; 124(6):984-6.
Score: 0.114
-
Bartoszek M, Brenner AM, Szefler SJ. Prednisolone and methylprednisolone kinetics in children receiving anticonvulsant therapy. Clin Pharmacol Ther. 1987 Oct; 42(4):424-32.
Score: 0.072
-
Szefler SJ, Ebling WF, Georgitis JW, Jusko WJ. Methylprednisolone versus prednisolone pharmacokinetics in relation to dose in adults. Eur J Clin Pharmacol. 1986; 30(3):323-9.
Score: 0.064
-
Szefler SJ, Brenner M, Jusko WJ, Spector SL, Flesher KA, Ellis EF. Dose- and time-related effect of troleandomycin on methylprednisolone elimination. Clin Pharmacol Ther. 1982 Aug; 32(2):166-71.
Score: 0.050
-
Szefler SJ, Ellis EF, Brenner M, Rose JQ, Spector SL, Yurchak AM, Andrews F, Jusko WJ. Steroid-specific and anticonvulsant interaction aspects of troleandomycin-steroid therapy. J Allergy Clin Immunol. 1982 May; 69(5):455-60.
Score: 0.049
-
Szefler SJ, Rose JQ, Ellis EF, Spector SL, Green AW, Jusko WJ. The effect of troleandomycin on methylprednisolone elimination. J Allergy Clin Immunol. 1980 Dec; 66(6):447-51.
Score: 0.045
-
Fost DA, Leung DY, Martin RJ, Brown EE, Szefler SJ, Spahn JD. Inhibition of methylprednisolone elimination in the presence of clarithromycin therapy. J Allergy Clin Immunol. 1999 Jun; 103(6):1031-5.
Score: 0.040
-
Kamada AK, Hill MR, Ikl? DN, Brenner AM, Szefler SJ. Efficacy and safety of low-dose troleandomycin therapy in children with severe, steroid-requiring asthma. J Allergy Clin Immunol. 1993 Apr; 91(4):873-82.
Score: 0.026
-
Greos LS, Vichyanond P, Bloedow DC, Irvin CG, Larsen GL, Szefler SJ, Hill MR. Methylprednisolone achieves greater concentrations in the lung than prednisolone. A pharmacokinetic analysis. Am Rev Respir Dis. 1991 Sep; 144(3 Pt 1):586-92.
Score: 0.024
-
Ball BD, Hill MR, Brenner M, Sanks R, Szefler SJ. Effect of low-dose troleandomycin on glucocorticoid pharmacokinetics and airway hyperresponsiveness in severely asthmatic children. Ann Allergy. 1990 Jul; 65(1):37-45.
Score: 0.022
-
Szefler SJ. Measuring the response to glucocorticoids. J Allergy Clin Immunol. 1990 Jun; 85(6):985-7.
Score: 0.022
-
Vichyanond P, Irvin CG, Larsen GL, Szefler SJ, Hill MR. Penetration of corticosteroids into the lung: evidence for a difference between methylprednisolone and prednisolone. J Allergy Clin Immunol. 1989 Dec; 84(6 Pt 1):867-73.
Score: 0.021
-
Ebling WF, Rich SA, Szefler SJ, Jusko WJ. Troleandomycin effects on methylprednisolone and methylprednisone interconversion and disposition in the rabbit. Eur J Drug Metab Pharmacokinet. 1987 Jan-Mar; 12(1):50-7.
Score: 0.017
-
Ebling WF, Milsap RL, Szefler SJ, Jusko WJ. 6 alpha-Methylprednisolone and 6 alpha-methylprednisone plasma protein binding in humans and rabbits. J Pharm Sci. 1986 Aug; 75(8):760-3.
Score: 0.017
-
Ebling WF, Szefler SJ, Jusko WJ. Methylprednisolone disposition in rabbits. Analysis, prodrug conversion, reversible metabolism, and comparison with man. Drug Metab Dispos. 1985 May-Jun; 13(3):296-304.
Score: 0.015
-
Ebling WF, Szefler SJ, Jusko WJ. Analysis of cortisol, methylprednisolone, and methylprednisolone hemisuccinate. Absence of effects of troleandomycin on ester hydrolysis. J Chromatogr. 1984 Feb 10; 305(2):271-80.
Score: 0.014
-
LaForce CF, Szefler SJ, Miller MF, Ebling W, Brenner M. Inhibition of methylprednisolone elimination in the presence of erythromycin therapy. J Allergy Clin Immunol. 1983 Jul; 72(1):34-9.
Score: 0.013
-
Hill MR, Szefler SJ, Ball BD, Bartoszek M, Brenner AM. Monitoring glucocorticoid therapy: a pharmacokinetic approach. Clin Pharmacol Ther. 1990 Oct; 48(4):390-8.
Score: 0.006
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|